Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 10/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 10/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.36 |
| ▸ | GSPT1 | P15170 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31355879 | 0.93 | DDB1 (0.36) | DDB1CRBNHDAC6GSPT1 | |
| SCHEMBL31356277 | 0.88 | HDAC6 (0.45) | DDB1CRBNHDAC6GSPT1HDAC1 | |
| SCHEMBL31356186 | 0.87 | CRBN (0.36) | DDB1CRBN | |
| SCHEMBL31356204 | 0.86 | CRBN (0.36) | DDB1CRBN | |
| SCHEMBL31356086 | 0.85 | DDB1 (0.31) | DDB1CRBN | |
| SCHEMBL31356211 | 0.81 | DDB1 (0.34) | DDB1CRBN | |
| SCHEMBL31356215 | 0.81 | DDB1 (0.44) | DDB1CRBNGSPT1 | |
| SCHEMBL31356045 | 0.81 | CRBN (0.36) | DDB1CRBNHDAC6GSPT1 | |
| SCHEMBL31355904 | 0.80 | CRBN (0.47) | DDB1CRBNHDAC6GSPT1CNR2 | |
| SCHEMBL31355813 | 0.79 | DDB1 (0.46) | DDB1CRBNHDAC6GSPT1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025026422-A1 | ARYL OR HETEROARYL SUBSTITUTED GLUTARIMIDE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2025-02-06 | — | — | WO | claimed |